|
| Press Releases |
|
 |
|
| Monday, March 7, 2022 |
|
|
EC Healthcare Included as an Eligible Stock of the Shenzhen - Hong Kong Stock Connect |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Company has been included as an eligible stock of Shenzhen-Hong Kong Stock Connect more info >> |
|
|
EC Healthcare and ClinicONE jointly launch A.I. Remote Nursing Program |
| EC Healthcare and ClinicONE jointly launched the intelligent remote health management platform Health.Me2 today. more info >> |
|
| Friday, March 4, 2022 |
|
|
医思健康携手ClinicONE推出A.I.遥距看护计划 |
| 医思健康携手ClinicONE (诊所一号) 今日正式推出Health•Me2 智能遥距健康管理平台。透过IoT云端技术配合AI智能医疗分析和专业医护团队，远程监察和评估用户的健康状况。 more info >> |
|
|
醫思健康攜手ClinicONE推出A.I.遙距看護計劃 |
| 醫思健康攜手ClinicONE (診所一號) 今日正式推出Health•Me2 智能遙距健康管理平台。透過IoT雲端技術配合AI智能醫療分析和專業醫護團隊，遠程監察和評估用戶的健康狀況。 more info >> |
|
| Monday, February 28, 2022 |
|
|
医思健康管理层再度增持公司股份 对集团发展前景充满信心 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，继集团日前披露有关截至2022年1月17日止之管理层股份增持情况后，于2022年2月21日至22日，集团主席、行政总裁及执行董事邓志辉先生分别再度于公开市场新增购入合共605,000股，涉资逾496万港元。 more info >> |
|
|
醫思健康管理層再度增持公司股份 對集團發展前景充滿信心 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，繼集團日前披露有關截至2022年1月17日止之管理層股份增持情況後，於2022年2月21日至22日，集團主席、行政總裁及執行董事鄧志輝先生分别再度於公開市場新增購入合共605,000股，涉資逾496萬港元。 more info >> |
|
|
Senior Management Further Increases Shareholdings in EC Healthcare With Strong Confidence in the Group's Future Development |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group's Chairman, Executive Director and Chief Executive Officer Mr. Tang Chi Fai further increases the shareholdings post the equity stake increase announced on January 17. more info >> |
|
| Friday, February 18, 2022 |
|
|
医思健康获纳入恒生综合指数及恒生港股通指数 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，集团已获恒生指数有限公司选为，并将纳入以下指数成份股，相关变动将于2022年3月7日正式生效。 more info >> |
|
|
醫思健康獲納入恒生綜合指數及恒生港股通指數 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，集團已獲恒生指數有限公司選為，並將納入以下指數成份股，相關變動將於2022年3月7日正式生效。 more info >> |
|
|
EC Healthcare Included in the Hang Seng Composite Index & Hang Seng Stock Connect Hong Kong Index |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group has been selected and will be included as a constituent stock of the following index series by Hang Seng Indexes Company Limited, with effect from 7 March 2022 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
珠宝双展匯聚逾82,000环球买家
Mar 9, 2025 13:51 HKT/SGT
|
|
|
珠寶雙展匯聚逾82,000環球買家
Mar 9, 2025 13:41 HKT/SGT
|
|
|
Twin jewellery shows attract over 82,000 global buyers
Mar 9, 2025 13:19 HKT/SGT
|
|
|
OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million
Mar 8, 2025 19:40 HKT/SGT
|
|
|
Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation
Mar 8, 2025 19:20 HKT/SGT
|
|
|
uSMART Securities Initiates Coverage on NAAS Technology with a 'Buy' Rating and a Target Price of US$3.2 per ADS, Citing Industry Leadership and Profitability Outlook
Mar 7, 2025 21:26: JST
|
|
|
Everest Medicines Hits Three-Year High as AI+mRNA Pipeline Reshapes Valuation
Mar 7, 2025 20:31: JST
|
|
|
uSMART Securities Initiates Coverage on NAAS Technology with a 'Buy' Rating and a Target Price of US$3.2 per ADS, Citing Industry Leadership and Profitability Outlook
Mar 7, 2025 20:26 HKT/SGT
|
|
|
雲頂新耀股價創3年新高 AI+mRNA賦能管線重塑估值
Mar 7, 2025 19:24 HKT/SGT
|
|
|
云顶新耀股价创3年新高 AI+mRNA赋能管线重塑估值
Mar 7, 2025 19:16 HKT/SGT
|
|
|
業聚醫療連續四年實現收入增長 達1.64億美元創新高 純利達3,970萬美元 建議派發末期股息每股10港仙
Mar 7, 2025 18:28 HKT/SGT
|
|
|
业聚医疗连续四年实现收入增长 达1.64亿美元创新高 纯利达3,970万美元 建议派发末期股息每股10港仙
Mar 7, 2025 18:10 HKT/SGT
|
|
|
東信營銷科技：中國AI營銷龍頭斬獲多模態雙備案 技術實力獲國家級認證
Mar 7, 2025 17:58 HKT/SGT
|
|
|
东信营销科技：中国AI营销龙头斩获多模态双备案 技术实力获国家级认证
Mar 7, 2025 17:20 HKT/SGT
|
|
|
Japan's Telecommunications Carriers Enhance Disaster Response with On-site Training for Joint Use of Marine Vessels
Mar 7, 2025 16:24 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
